Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features
Mauro F.R., Foa R., Cerretti R., et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood 95 9 (2000) 2786-2792
Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light chain diversity in VH4-34 expressing single leukemic B cells
Ruzickova S., Pruss A., Odendahl M., et al. Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light chain diversity in VH4-34 expressing single leukemic B cells. Blood 100 9 (2002) 3419-3422
Cold agglutinin disease by autoanti-i blood type antibody associated with B cell chronic lymphocytic leukemia
Ishida F., Saito H., Kitano K., and Kiyosawa K. Cold agglutinin disease by autoanti-i blood type antibody associated with B cell chronic lymphocytic leukemia. Int J Hematol 67 (1998) 69-73
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia
Dearden C., Wade R., Else M., et al. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood 111 4 (2008) 1820-1826
Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy
Mori A., Tamaru J.I., Sumi H., and Kondo H. Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy. Eur J Haematol 68 (2002) 243-246
Development of cold agglutinin autoimmune hemolytic anemia during treatment for pediatric acute lymphocytic leukemia
Teachey D.T., and Felix C.A. Development of cold agglutinin autoimmune hemolytic anemia during treatment for pediatric acute lymphocytic leukemia. J Pediatr Hematol Oncol 27 7 (2005) 397-399